Mutual Advisors’s Rockwell Medical RMTI Stock Holding History

Mutual Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,200	Closed	-$10.7K	–	1446
2026 Q1	$10.7K	Hold	1,200	–	–	﹤0.01%	1320
2025 Q4	$10K	Buy	+1,200	New	+$12.1K	﹤0.01%	1290

Other funds holding RMTI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mutual Advisors's RMTI Position: Q2 2026 in Review

Mutual Advisors sold out of Rockwell Medical (RMTI) in Q2 2026, closing a stake of 1,200 shares — an estimated $10.7K sold.

Mutual Advisors first reported a position in RMTI in Q4 2025 and held it in 2 quarters. The position peaked at $10.7K in Q1 2026. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

Mutual Advisors reported no remaining Rockwell Medical position as of Q2 2026 after selling out during the quarter.
Mutual Advisors sold 1,200 Rockwell Medical shares in Q2 2026, an estimated $10.7K.
Mutual Advisors first reported a position in Rockwell Medical in Q4 2025 and held it in 2 quarters.
Mutual Advisors's Rockwell Medical position peaked at $10.7K in Q1 2026.
37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.